Real World Case Series: Integrated Skincare With Advanced RGN ‐6 Serum
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Andrew Alexis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Cosmetic Techniques, Dermatologic Agents, Rejuvenation, Skin Aging. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Skin aging is a multifactorial process with intrinsic and extrinsic factors that lead to visible signs of aging, including loss of skin elasticity, volume, dyspigmentation, wrinkles, fine lines, and dry and uneven skin. The advanced RGN‐6 serum is a patent‐pending, multi‐ingredient serum that has been developed to address 6 dimensions of skin regeneration and combat visible signs of aging. The six dimensions of skin regeneration include: (1) barrier re‐epithelialization, (2) redness and inflammation, (3) cellular energy stimulation, (4) elastin and collagen stimulation, (5) antioxidants, and (6) postinflammatory hyperpigmentation (PIH). To address these factors, the RGN‐6 serum contains six active ingredients: 1% eperuline, 0.2% ectoin, 10% glycorepair, 0.2% bioceramide 603, 3% acetyl tetrapeptide‐9, and 2% niacinamide. This multi‐ingredient serum works to simultaneously target the most common signs of aging.
Aim
To provide detailed evidence for multiple integrated skincare regimens using the advanced RGN‐6 serum in facial rejuvenation.
Methods
In this real‐world case series, 6 expert dermatologists with extensive experience in cosmetic and anti‐aging medicine shared and discussed patient cases of advanced RGN‐6 serum used in combination with energy‐based facial rejuvenation procedures in a subset of women with skin of color with Fitzpatrick skin types ranging from type 3 to type 6.
Results
After the panel discussion, six patient cases were selected to best demonstrate the use of RGN‐6 serum postprocedure.
Conclusion
The panel experts agreed that twice daily application of the RGN‐6 serum led to improved signs of redness, fine lines, and skin tone and evenness in all postprocedure patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Weill Cornell Medicine, New York, New York, USA.
- DermAtelier on Avenue, Faculty of Medicine University of Toronto, Toronto, Ontario, Canada.
- SkinCeuticals, New York, New York, USA.
- Mount Sinai Dermatology, New York, New York, USA.
- Connecticut Skin Institute, Milford, Connecticut, USA.
- Chroma Dermatology, Clinical Department of Dermatology, Royal Children's Hospital, Parkville, Victoria, Australia.
ORCID-Profile: Andrew Alexis, Renée A Beach, Patricia Brieva, Sophie Guénin, Omar A Ibrahimi, Michelle Rodrigues, Heather Woolery-Lloyd, Valerie Callender
Zitieren
APA
Alexis, A., Beach, R. A., Brieva, P., Guénin, S., Ibrahimi, O. A., Rodrigues, M., Woolery-Lloyd, H., & Callender, V. (2025). Real World Case Series: Integrated Skincare With Advanced RGN ‐6 Serum. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70303
Vancouver
Alexis A, Beach RA, Brieva P, Guénin S, Ibrahimi OA, Rodrigues M, et al. Real World Case Series: Integrated Skincare With Advanced RGN ‐6 Serum. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70303
BibTeX
@article{Alexis2025,
author = {Alexis, Andrew and Beach, Renée A and Brieva, Patricia and Guénin, Sophie and Ibrahimi, Omar A and Rodrigues, Michelle and Woolery-Lloyd, Heather and Callender, Valerie},
title = {Real World Case Series: Integrated Skincare With Advanced RGN ‐6 Serum},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70303}
}
EUVIMED